ESC 365 - Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.

ESC Premium Access

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial.

Session: Treatment of conundrum in acute heart failure

Topic: Acute Heart Failure

Speaker: Professor D. Morrow (Boston, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor David Morrow

Brigham and Women's Hospital, Boston (United States of America)

8 presentations

3 followers

4 more presentations in this session

State of the Art - TakoTsubo

Speaker: Doctor J. Ghadri (Zurich, CH)

Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial

Speaker: Doctor A. Ambrosy (San Francisco, US)

Prognostic impact of mineralocorticoid receptor antagonists in patients hospitalized for acute heart failure

Speaker: Doctor H. Yaku (Kyoto, JP)

A life support based comprehensive treatment regimen dramatically lowers the in-hospital mortality of patients with fulminant myocarditis ---- a multiple center study

Speaker: Doctor D. Wang (Nanjing, CN)

Access the full session

Treatment of conundrum in acute heart failure

Speakers: Professor D. Morrow, Doctor J. Ghadri, Doctor A. Ambrosy, Doctor H. Yaku, Doctor D. Wang

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources